ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img

Carbohydrate-Functionalized rGO as an Effective Cancer Vaccine for Stimulating Antigen-Specific Cytotoxic T Cells and Inhibiting Tumor Growth

View Author Information
† § ∥ School of Chemical Engineering, School of Pharmacy, §Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea
*E-mail: [email protected]; Tel.: +82-31-290-7252; Fax: +82-31-290-7272.
Cite this: Chem. Mater. 2017, 29, 16, 6883–6892
Publication Date (Web):July 28, 2017
https://doi.org/10.1021/acs.chemmater.7b02197
Copyright © 2017 American Chemical Society

    Article Views

    1314

    Altmetric

    -

    Citations

    30
    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (1)»

    Abstract

    Abstract Image

    Efficient delivery of antigens to dendritic cells (DCs), potent antigen-presenting cells, and subsequent antigen presentation to initiate the production of activated cytotoxic T cells are vital parameters that determine the success of cancer immunotherapy. Here, we report dextran-functionalized reduced graphene oxide (rGO-dextran) as an antigen delivery carrier for cancer immunotherapy. We synthesized dextran-functionalized rGO, where the dextran component facilitated good colloidal stability by exposing hydroxyl groups on the surface of reduced graphene oxide (rGO) and also enhanced cellular uptake via interaction with carbohydrate receptors present on DCs. High surface area and intrinsic hydrophobic surface of rGO facilitated high loading of the model antigen, ovalbumin (OVA). We found that rGO-dextran efficiently delivered OVA to DCs and enhanced the antigen presentation via major histocompatibility complex class I (MHC-I). In addition, the release of inflammatory cytokines, IL-12 and TNF-α, for DCs incubated with OVA-loaded rGO-dextran was remarkably higher than that for those incubated with soluble OVA. We also demonstrated that OVA-loaded rGO-dextran induced production of antigen-specific cytotoxic T cells in vivo and significantly inhibited tumor growth. Therefore, the proposed rGO-dextran could be a potent candidate for cancer vaccine and other immunotherapy.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.chemmater.7b02197.

    • Characterization of OVA-FITC loading, release profile of OVA-FITC from rGO-dextran, effect of rGO-dextran-40/rGO-dextran-6 on activation of BMDCs, effect of dextran OVA mixture and OVA@rGO on the maturation of BMDCs, and in vivo imaging of lymph node after subcutaneous injection of R6g@rGO-dextran in mice (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 30 publications.

    1. Ning Wang, Guiqiang Zhang, Haifeng Sun, Yuan Tian, Jingcheng Hao, Jiwei Cui. Vaccine Nanoparticles Derived from Mung Beans for Cancer Immunotherapy. Chemistry of Materials 2021, 33 (11) , 4057-4066. https://doi.org/10.1021/acs.chemmater.1c00629
    2. Zhenguang Liu, Jin He, Tianyu Zhu, Cong Hu, Ruonan Bo, Adelijiang Wusiman, Yuanliang Hu, Deyun Wang. Lentinan-Functionalized Graphene Oxide Is an Effective Antigen Delivery System That Modulates Innate Immunity and Improves Adaptive Immunity. ACS Applied Materials & Interfaces 2020, 12 (35) , 39014-39023. https://doi.org/10.1021/acsami.0c12078
    3. Jing Zhao, Zheng Chen, Shanbiao Liu, Pin Li, Shiyi Yu, Daishun Ling, Fangyuan Li. Nano‐bio interactions between 2D nanomaterials and mononuclear phagocyte system cells. BMEMat 2024, 13 https://doi.org/10.1002/bmm2.12066
    4. Bahareh Vakili, Mahboubeh Karami-Darehnaranji, Esmaeil Mirzaei, Farnaz Hosseini, Navid Nezafat. Graphene oxide as novel vaccine adjuvant. International Immunopharmacology 2023, 125 , 111062. https://doi.org/10.1016/j.intimp.2023.111062
    5. Ting Cheng, Ting Yan, Jinwei Wu, Qi Wang, Huijie Zhang. Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity. International Journal of Biological Macromolecules 2023, 234 , 123432. https://doi.org/10.1016/j.ijbiomac.2023.123432
    6. Khushbu Chauhan, Eunbin Cho, Dong-Eun Kim. Graphene Oxide and Nucleic Acids. 2023, 1765-1795. https://doi.org/10.1007/978-981-19-9776-1_62
    7. Lin Ding, Minli Liang, Chenchen Li, Xinting Ji, Junfeng Zhang, Weifen Xie, Rui L. Reis, Fu‐Rong Li, Shuo Gu, Yanli Wang. Design Strategies of Tumor‐Targeted Delivery Systems Based on 2D Nanomaterials. Small Methods 2022, 6 (11) https://doi.org/10.1002/smtd.202200853
    8. Khushbu Chauhan, Eunbin Cho, Dong-Eun Kim. Graphene Oxide and Nucleic Acids. 2022, 1-31. https://doi.org/10.1007/978-981-16-1313-5_62-1
    9. Koushik Debnath, Nikhil R. Jana. Ligand-Functionalized Nanostructures and Their Biomedical Applications. 2022, 445-457. https://doi.org/10.1007/978-981-16-4189-3_17
    10. Muhammad Amir Yunus, Muhammad Mahyiddin Ramli, Nurul Huda Osman, Rafeezul Mohamed. Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression. Archivum Immunologiae et Therapiae Experimentalis 2021, 69 (1) https://doi.org/10.1007/s00005-021-00625-6
    11. Zhongmin Tang, Yufen Xiao, Na Kong, Chuang Liu, Wei Chen, Xiangang Huang, Daiyun Xu, Jiang Ouyang, Chan Feng, Cong Wang, Junqing Wang, Han Zhang, Wei Tao. Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy. Acta Pharmaceutica Sinica B 2021, 11 (11) , 3447-3464. https://doi.org/10.1016/j.apsb.2021.05.004
    12. Chunhong Dong, Ye Wang, Gilbert X. Gonzalez, Yao Ma, Yufeng Song, Shelly Wang, Sang-Moo Kang, Richard W. Compans, Bao-Zhong Wang. Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains. Proceedings of the National Academy of Sciences 2021, 118 (19) https://doi.org/10.1073/pnas.2024998118
    13. Raghvendra Mishra, Shishir K. Singh, Himani Gupta, Nitin Srivastava, Dipika Meghnani, Rupesh K. Tiwari, Anupam Patel, Anurag Tiwari, Vimal K. Tiwari, Rajendra K. Singh. Surface modification of nano Na[Ni0.60Mn0.35Co0.05]O2 cathode material by dextran functionalized RGO via hydrothermal treatment for high performance sodium batteries. Applied Surface Science 2021, 535 , 147695. https://doi.org/10.1016/j.apsusc.2020.147695
    14. Hua Yue, Guanghui Ma. Advances in Functionalized Carriers Based on Graphene's Unique Biological Interface Effect. Acta Chimica Sinica 2021, 79 (10) , 1244. https://doi.org/10.6023/A21050238
    15. Arpit Bhargava, Dinesh Kumar Mishra, Rajnarayan Tiwari, Nirmal Kumar Lohiya, Irina Yu Goryacheva, Pradyumna Kumar Mishra. Immune cell engineering: opportunities in lung cancer therapeutics. Drug Delivery and Translational Research 2020, 10 (5) , 1203-1227. https://doi.org/10.1007/s13346-020-00719-2
    16. Wei Shi, Zhenzhen Tong, Qianqian Qiu, Na Yue, Weiwei Guo, Feng Zou, Daoguang Zhou, Jiuhui Li, Wenlong Huang, Hai Qian. Novel HLA-A2 restricted antigenic peptide derivatives with high affinity for the treatment of breast cancer expressing NY-ESO-1. Bioorganic Chemistry 2020, 103 , 104138. https://doi.org/10.1016/j.bioorg.2020.104138
    17. Mitra Dolatkhah, Nastaran Hashemzadeh, Jaleh Barar, Khosro Adibkia, Ayuob Aghanejad, Mohammad Barzegar-Jalali, Yadollah Omidi. Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer. Colloids and Surfaces B: Biointerfaces 2020, 193 , 111104. https://doi.org/10.1016/j.colsurfb.2020.111104
    18. Wanjun Cao, Lin He, Weidong Cao, Xiaobing Huang, Kun Jia, Jingying Dai. Recent progress of graphene oxide as a potential vaccine carrier and adjuvant. Acta Biomaterialia 2020, 112 , 14-28. https://doi.org/10.1016/j.actbio.2020.06.009
    19. Xiqin Yang, Tong Yu, Yingping Zeng, Keke Lian, Xueqing Zhou, Sufen Li, Guoxi Qiu, Xiangyu Jin, Hong Yuan, Fuqiang Hu. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Carbohydrate Polymers 2020, 240 , 116270. https://doi.org/10.1016/j.carbpol.2020.116270
    20. Cui Song, Feng Li, Shuang Wang, Jianghua Wang, Wei Wei, Guanghui Ma. Recent Advances in Particulate Adjuvants for Cancer Vaccination. Advanced Therapeutics 2020, 3 (5) https://doi.org/10.1002/adtp.201900115
    21. Yue Yin, Thanh Loc Nguyen, Bo Wang, Huu Thuy Trang Duong, Doo Sung Lee, Ji-Heung Kim, Jaeyun Kim, Ji Hoon Jeong. Simultaneous delivery of DNA vaccine and hydrophobic adjuvant using reducible polyethylenimine-functionalized graphene oxide for activation of dendritic cells. Journal of Industrial and Engineering Chemistry 2019, 80 , 870-876. https://doi.org/10.1016/j.jiec.2019.08.038
    22. Thanh Loc Nguyen, Youngjin Choi, Jaeyun Kim. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy. Advanced Materials 2019, 31 (34) https://doi.org/10.1002/adma.201803953
    23. Weijing Yang, Zijian Zhou, Joseph Lau, Shuo Hu, Xiaoyuan Chen. Functional T cell activation by smart nanosystems for effective cancer immunotherapy. Nano Today 2019, 27 , 28-47. https://doi.org/10.1016/j.nantod.2019.05.004
    24. Arjyabaran Sinha, Youngjin Choi, Minh Hoang Nguyen, Thanh Loc Nguyen, Seung Woo Choi, Jaeyun Kim. A 3D Macroporous Alginate Graphene Scaffold with an Extremely Slow Release of a Loaded Cargo for In Situ Long‐Term Activation of Dendritic Cells. Advanced Healthcare Materials 2019, 8 (5) https://doi.org/10.1002/adhm.201800571
    25. Hatem A.F.M. Hassan, Sandra S. Diebold, Lesley A. Smyth, Adam A. Walters, Giovanna Lombardi, Khuloud T. Al-Jamal. Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chances. Journal of Controlled Release 2019, 297 , 79-90. https://doi.org/10.1016/j.jconrel.2019.01.017
    26. Eun Sook Lee, Jung Min Shin, Soyoung Son, Hyewon Ko, Wooram Um, Seok Ho Song, Jae Ah Lee, Jae Hyung Park. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy. Advanced Healthcare Materials 2019, 8 (4) https://doi.org/10.1002/adhm.201801320
    27. Xiaoli Wang, Fengqiang Cao, Mengmeng Yan, Yijia Liu, Xianghui Zhu, Hongfan Sun, Guilei Ma. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination. Acta Biomaterialia 2019, 83 , 390-399. https://doi.org/10.1016/j.actbio.2018.11.023
    28. Anna Piperno, Angela Scala, Antonino Mazzaglia, Giulia Neri, Rosamaria Pennisi, Maria Sciortino, Giovanni Grassi. Cellular Signaling Pathways Activated by Functional Graphene Nanomaterials. International Journal of Molecular Sciences 2018, 19 (11) , 3365. https://doi.org/10.3390/ijms19113365
    29. Hong Yeol Yoon, Subramanian Tamil Selvan, Yoosoo Yang, Min Ju Kim, Dong Kee Yi, Ick Chan Kwon, Kwangmeyung Kim. Engineering nanoparticle strategies for effective cancer immunotherapy. Biomaterials 2018, 178 , 597-607. https://doi.org/10.1016/j.biomaterials.2018.03.036
    30. Zhen Liu, Jingquan Liu, Tao Wang, Qiong Li, Paul S. Francis, Colin J. Barrow, Wei Duan, Wenrong Yang. Switching off the interactions between graphene oxide and doxorubicin using vitamin C: combining simplicity and efficiency in drug delivery. Journal of Materials Chemistry B 2018, 6 (8) , 1251-1259. https://doi.org/10.1039/C7TB03063K

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect